Humanwell Healthcare Group Co Ltd Cash Flow Conversion Efficiency
Humanwell Healthcare Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Humanwell Healthcare Group Co Ltd (600079) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥829.91 Million ≈ $121.44 Million USD) by net assets (CN¥21.92 Billion ≈ $3.21 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Humanwell Healthcare Group Co Ltd (1998–2025)
Cash flow conversion efficiency of Humanwell Healthcare Group Co Ltd from 1998 to 2025. This chart illustrates how Humanwell Healthcare Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 600079 live share price for real-time trading data and today's change.
Humanwell Healthcare Group Co Ltd Cash Flow Conversion Ratio Explained
Humanwell Healthcare Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Humanwell Healthcare Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Humanwell Healthcare Group Co Ltd ranked by their cash flow conversion efficiency. Also see Humanwell Healthcare Group Co Ltd stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BillionToOne, Inc. Class A Common Stock
NASDAQ:BLLN
|
0.017x |
|
Zhejiang Hailiang Co Ltd
SHE:002203
|
0.064x |
|
FLSmidth & Co.
CO:FLS
|
0.010x |
|
Iridium Communications Inc
NASDAQ:IRDM
|
0.242x |
|
Piper Sandler Companies
NYSE:PIPR
|
0.038x |
|
Xian Sunresin New Materials Co Ltd
SHE:300487
|
0.055x |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
N/A |
|
Insight Enterprises Inc
NASDAQ:NSIT
|
0.013x |
Annual Cash Flow Conversion Efficiency for Humanwell Healthcare Group Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Humanwell Healthcare Group Co Ltd from 1998 to 2025. Review Humanwell Healthcare Group Co Ltd (600079) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥22.01 Billion ≈ $3.22 Billion |
CN¥2.52 Billion ≈ $368.57 Million |
0.114x | +9.43% |
| 2024-12-31 | CN¥20.69 Billion ≈ $3.03 Billion |
CN¥2.16 Billion ≈ $316.70 Million |
0.105x | +6.85% |
| 2023-12-31 | CN¥20.10 Billion ≈ $2.94 Billion |
CN¥1.97 Billion ≈ $287.87 Million |
0.098x | -28.06% |
| 2022-12-31 | CN¥17.94 Billion ≈ $2.63 Billion |
CN¥2.44 Billion ≈ $357.21 Million |
0.136x | -2.27% |
| 2021-12-31 | CN¥15.65 Billion ≈ $2.29 Billion |
CN¥2.18 Billion ≈ $318.83 Million |
0.139x | -9.08% |
| 2020-12-31 | CN¥12.99 Billion ≈ $1.90 Billion |
CN¥1.99 Billion ≈ $290.98 Million |
0.153x | +6.92% |
| 2019-12-31 | CN¥14.23 Billion ≈ $2.08 Billion |
CN¥2.04 Billion ≈ $298.20 Million |
0.143x | +243.92% |
| 2018-12-31 | CN¥14.48 Billion ≈ $2.12 Billion |
CN¥602.99 Million ≈ $88.24 Million |
0.042x | +1737.75% |
| 2017-12-31 | CN¥16.85 Billion ≈ $2.47 Billion |
CN¥38.17 Million ≈ $5.59 Million |
0.002x | -94.84% |
| 2016-12-31 | CN¥11.98 Billion ≈ $1.75 Billion |
CN¥526.48 Million ≈ $77.04 Million |
0.044x | +29.63% |
| 2015-12-31 | CN¥9.18 Billion ≈ $1.34 Billion |
CN¥311.22 Million ≈ $45.54 Million |
0.034x | -61.38% |
| 2014-12-31 | CN¥5.73 Billion ≈ $838.16 Million |
CN¥502.70 Million ≈ $73.56 Million |
0.088x | -10.50% |
| 2013-12-31 | CN¥5.08 Billion ≈ $743.41 Million |
CN¥498.22 Million ≈ $72.90 Million |
0.098x | +107.76% |
| 2012-12-31 | CN¥3.65 Billion ≈ $534.05 Million |
CN¥172.27 Million ≈ $25.21 Million |
0.047x | +57.24% |
| 2011-12-31 | CN¥3.14 Billion ≈ $459.33 Million |
CN¥94.23 Million ≈ $13.79 Million |
0.030x | -37.27% |
| 2010-12-31 | CN¥2.33 Billion ≈ $340.61 Million |
CN¥111.39 Million ≈ $16.30 Million |
0.048x | -35.56% |
| 2009-12-31 | CN¥2.08 Billion ≈ $304.49 Million |
CN¥154.51 Million ≈ $22.61 Million |
0.074x | +163.33% |
| 2008-12-31 | CN¥1.24 Billion ≈ $181.47 Million |
CN¥34.97 Million ≈ $5.12 Million |
0.028x | -40.22% |
| 2007-12-31 | CN¥1.17 Billion ≈ $170.79 Million |
CN¥55.05 Million ≈ $8.06 Million |
0.047x | -38.05% |
| 2006-12-31 | CN¥1.11 Billion ≈ $162.28 Million |
CN¥84.44 Million ≈ $12.36 Million |
0.076x | -53.95% |
| 2005-12-31 | CN¥768.89 Million ≈ $112.51 Million |
CN¥127.13 Million ≈ $18.60 Million |
0.165x | +69.79% |
| 2004-12-31 | CN¥724.52 Million ≈ $106.02 Million |
CN¥70.55 Million ≈ $10.32 Million |
0.097x | +37.37% |
| 2003-12-31 | CN¥681.54 Million ≈ $99.73 Million |
CN¥48.31 Million ≈ $7.07 Million |
0.071x | +169.37% |
| 2002-12-31 | CN¥682.71 Million ≈ $99.90 Million |
CN¥-69.77 Million ≈ $-10.21 Million |
-0.102x | -340.11% |
| 2001-12-31 | CN¥396.54 Million ≈ $58.03 Million |
CN¥16.88 Million ≈ $2.47 Million |
0.043x | -47.20% |
| 2000-12-31 | CN¥325.09 Million ≈ $47.57 Million |
CN¥26.20 Million ≈ $3.83 Million |
0.081x | +192.00% |
| 1999-12-31 | CN¥290.76 Million ≈ $42.55 Million |
CN¥-25.47 Million ≈ $-3.73 Million |
-0.088x | -747.02% |
| 1998-12-31 | CN¥201.81 Million ≈ $29.53 Million |
CN¥2.73 Million ≈ $399.87K |
0.014x | -- |
About Humanwell Healthcare Group Co Ltd
Humanwell Healthcare (Group) Co.,Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers sufentanil citrate injection, an analgesic drug for combined anesthesia; remifentanil hydrochloride injection for induction of general anesthesia and maintenance of analgesia during general anesthesia; hydromorphone hydrochloride injection for pa… Read more